Bone changes in early rheumatoid arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 15, Issue 1, 2001, Pages 105-123

  Green, Michael J ^a   Deodhar, Atul A ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Hand bone densitometry; Osteoporosis; Osteoprotegerin; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; CYTOKINE; DEFLAZACORT; ESTRADIOL VALERATE; ESTROGEN; ETANERCEPT; HORMONE; HYDROXYCHLOROQUINE; INFLIXIMAB; LIGAND; MEMBRANE PROTEIN; METHOTREXATE; OSTEOPROTEGERIN; PAMIDRONIC ACID; PLACEBO; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; SALCATONIN; TESTOSTERONE; TUMOR NECROSIS FACTOR;

BONE ATROPHY; BONE DENSITY; BONE DISEASE; BONE EROSION; BONE MASS; BONE MINERAL; CLINICAL TRIAL; DENSITOMETRY; DISEASE ACTIVITY; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXPERIMENTAL MODEL; HAND DISEASE; HORMONE SUBSTITUTION; HUMAN; INFLAMMATION; METABOLIC ACTIVATION; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOPOROSIS; PERIARTICULAR JOINT DISEASE; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SKELETON; SYNOVIOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0035041256     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.2000.0129     Document Type: Article

References (55)

1. Radiographic changes in early rheumatoid disease
2. American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
3. Bone mass measurement and bone metabolism in rheumatoid arthritis: A review
4. Osteoporosis in rheumatoid arthritis - The clinical view point
5. Bone mineral density in patients with recent onset rheumatoid arthritis: Influence of disease activity and functional capacity
6. Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: A longitudinal study
7. Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis?
8. Fractures after rheumatoid arthritis: A population based study
9. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
10. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
11. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
12. Regulation of the differentiation and function of osteoclasts
13. Involvement of receptor activator of nuclear factor kB ligand/osteoclast differentiation factor on osteoclastogenesis from synoviocytes in rheumatoid arthritis
14. Activated human T cells induce osteoclast differentiation from peripheral monocytes via expression of osteoclast differentiation factor (ODF)/RANKL/TRANCE/OPGL
15. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
16. Metalloproteinases and tissue damage
17. Mast cells, cytokines and metalloproteinases at the rheumatoid lesion: Dual immunolocalization studies
18. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis
19. Determination of stromolysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis
20. Serum MMP-3 in rheumatoid arthritis: Correlation with systemic inflammation but not with erosive status
21. Rheumatoid arthritis, corticosteroid therapy and hip fracture
22. Risk of vertebral fracture in women with rheumatoid arthritis
23. Stress fractures of the pubic rami in rheumatoid arthritis
24. Quantitative computed tomography of the rheumatic knee
25. Measurement of hand bone mineral content using single photon absorptiometry
26. A UK consensus group on management of glucocorticoid induced osteoporosis
27. Evaluation of finger ultrasound in the assessment of bone status with application of rheumatoid arthritis
28. Axial bone density in rheumatoid arthritis: Comparison of dual energy projection radiography and dual photon absorptiometry
29. Generalised bone loss in patients with early rheumatoid arthritis
30. Longitudinal bone mineral density changes in early rheumatoid arthritis
31. Bone mineral density of the hand in rheumatoid arthritis
32. Measurement of hand bone mineral content by dual energy absorptiometry: Development of the method, and its application in normal volunteers and in patients with rheumatoid arthritis
33. Osteoporosis in rheumatoid arthritis: A monozygotic co-twin control study
34. Methods of scoring the progression of radiologic changes in rheumatoid arthritis
35. Clinical associations of dual-energy x-ray absorptiometry measurement in rheumatoid arthritis
36. Serial hand bone densitometry with Lunar-XL densitometer in the assessment of patients with very early inflammatory arthritis
37. Longitudinal study of hand bone densitometry in rheumatoid arthritis
38. A five-year longitudinal study of hand bone densitometry in early rheumatoid arthritis
39. Should we look for osteoporosis in patients with rheumatoid arthritis?
40. Treatment of poor prognosis early rheumatoid arthritis: Ongoing study of conventional therapy with sulphasalazine versus aggressive therapy with methotrexate, cyclosporin-A and intra-articular corticosteroids
41. Longitudinal hand bone densitometry to assess efficacy and toxicity of intra-articular (ia) corticosteroid (cs) injections in severe RA
42. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine, with sulphasalazine alone in early rheumatoid arthritis
43. Established rheumatoid arthritis
44. Bone loss in rheumatoid arthritis and in primary generalised osteoarthrosis: Effects of corticosteroids, suppressive antirheumatic drugs and calcium supplements
45. Effects of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids
46. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis
47. Effects of hormone replacement therapy in rheumatoid arthritis: A double blind placebo-controlled study
48. Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a 3-year randomized, double blind trial
49. Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy?
50. Intranasal calcitonin for the prevention of bone erosion and loss in rheumatoid arthritis
51. A randomized trial of testosterone therapy in males with rheumatoid arthritis
52. Physical activity as a determinant of bone conservation in the radial diaphysis in rheumatoid arthritis
53. A phase III trial of etanercept vs methotrexate in early RA
54. Two-year longitudinal bone densitometry to assess efficacy and toxicity of combination therapy including intra-articular corticosteroid injections in severe early RA